As the Digital Operation Platform for Biopharma Industry, Taimei Technology aims at empowering our clients across drug R&D, pharmacovigilance, marketing and market access with the comprehensive professional software product suite and technology-based professional service system. Our comprehensive software product suite includes eCooperate(CTMS), eCollect(EDC), eArchive(eTMF), eBalance(IWRS), eVisit(ePRO), eImage, eSafety, eSite, eTrial, eCollege, CRM, to name but a few.
Led by the core concept of “cooperation”, our TrialOS drug digital cooperation platform integrate stakeholders from pharmaceutical enterprises, GCP sites, providers, regulators, patients to other stakeholders. We are poised to advance the value upgrade and realize a win-win situation for all parties by leveraging resource integration, data interaction, process cooperation and standard unification.
With the application of advanced technologies such as artificial intelligence, Taimei Technology provides clinical trial data management, biostatistics, independent reading committee and pharmacovigilance services to our clients. By equipping with the professional software suite, TrialOS platform, professional service capability and data-driven evidence, Taimei Technology work closely with our strategic partners to provide total solutions in clinical research and pharmacovigilance.
Guided by our mission of accelerating the accessibility of innovative drugs, Taimei Technology is forming the infrastructure for the future development of pharmaceutical industry. Our goals are to accelerate the process of new drug R&D, improve drug accessibility, ensure patients’ safety use of drugs and reduce the patient's medical burden.
Today, Taimei Technology has become the reliable partner for more than 500 leading pharmaceutical companies and CROs in China and abroad and cooperated with 1,600+ hospitals. The TrialOS platform supports 1/3 of China's registered clinical research and 1/5 of ADR submission.
As the first enterprise to access National ADR Direct Reporting System, Taimei Technology has product service suite is authorized by ISO Certifications, Class III information system security protection of the Ministry of Public Security and certification of Trusted Cloud, enterprise-class SaaS Evaluation.
Taimei Technology is also the National Hi-Tech enterprise and certified vendor of CDISC and WHO-UMC.
A professional team of 900+ employees from R&D, data management, biostatistics, clinical trial, pharmacovigilance, business developement and other functions.
20%+ employees hold master's degree or above, 20%+ employees graduate from 985/211 universities, Ensure the input of outstanding talents through college cooperation programs.
400+ industry experts in product and R&D team, most of them worked for top technology companies such as Tencent, Huawei, Alibaba and 360 before joining. Constantly introduce professionals from well-known pharmaceutical companies, CRO, hospitals.
Product Design Standards
Validation in compliance with industry standards
- Title 21 CFR Part 11（International Basic Standards）
- CDISC（Data Interchange Standard）
- GAMP5（System Verification Standard）
- ICH-E2B（Data Interchange Standard）
Qualifications of international certified vendor
- WHO-UMC certified vendor
- CDISC member and registered vendor
Docking with domestic and foreign regulatory agencies database
- Completed system docking with ADR direct reporting system